TONGJITANG CHINESE MEDICINES COMPANY SHARE OPTION AGREEMENTShare Option Agreement • March 18th, 2008 • Wang Xiaochun • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2008 Company IndustryEffective on the Grant Date, you have been granted an the option to purchase the number of Shares of the Company at the exercise price designated above, in accordance with the provisions of Tongjitang Chinese Medicines Company 2006 Share Incentive Plan, as amended (the “Plan”). This option may be exercised for whole shares only.
TONGJITANG CHINESE MEDICINES COMPANY RESTRICTED SHARES AWARD AGREEMENTRestricted Shares Award Agreement • March 18th, 2008 • Wang Xiaochun • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2008 Company IndustryEffective on the Grant Date you have been granted the Restricted Shares of the Company, in accordance with the provisions of the Tongjitang Chinese Medicines Company 2006 Share Incentive Plan (the “Plan”) and subject to the restrictions, terms and conditions set forth herein.
JOINT FILING AGREEMENTJoint Filing Agreement • March 18th, 2008 • Wang Xiaochun • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2008 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to file a joint statement containing the information required by Schedule 13D, including any amendments thereto, with respect to the beneficial ownership by each of the undersigned of Ordinary Shares of Tongjitang Chinese Medicines Company.
EXHIBIT A: Joint Filing AgreementJoint Filing Agreement • February 13th, 2008 • Wang Xiaochun • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2008 Company IndustryIn accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.001 per share, of Tongjitang Chinese Medicines Company, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.